Skip to content

About
- Who We Are
- Our Team
- News
- Psychedelics
- FAQ
Patients
Training
Clinical Trial
- PsilWell Clinical Trial
- Global Evidence
Advocacy
Community
- Events
- Membership
- Volunteer
- Newsletter
- Allies
Store
- Right to Try Organic Cotton Tote
Donate

John

In this National Post opinion piece, Ben Woodfinden argues that MP Corey Tochor’s private member’s bill C-286 — which would let doctors prescribe psilocybin for depression and fast-track its regulatory approval — deserves serious committee debate when Parliament returns in September. Read the piece here.

Thomas’ Bill was tabled in Parliament. We crossed 900 practitioners trained, now working in 14 countries. Patients are accessing care in ways they couldn’t before. We put together a full look back at the first half of 2026, covering everything from legislative wins to the people doing this work. Read the H1 2026 report →

A Japanese-American woman with advanced Alzheimer’s disease showed noticeable improvements – which included reciting personal memories – after she took a high dose of magic mushrooms, according to a case study. TheraPsil’s Clinical Research Manager, Kamaya Lawrence, was featured in CTV’s story on the study. Read the full story on CTV here.

Conservative MP Corey Tochor introduced new legislation on Tuesday to legalize prescribing psychedelics like psilocybin (colloquially known as magic mushrooms), which researchers and patients say can effectively treat some mental health disorders. Read the full story here.

A Canadian psychiatrist explores the growing body of research showing that psilocybin therapy may offer new hope for the estimated 700,000 Canadians living with treatment-resistant depression. Read the story here.

MP Marcus Powlowski · Private Member’s Bill Support Bill C-265 A bill to reform Canada’s Special Access Program and improve patient access to essential medications. Write to Your MP Join the May 14 Webinar MPs need to hear from healthcare professionals like you.

A new University of Victoria study has found some people living with traumatic brain injuries are turning to psychedelics in an attempt to manage symptoms like headaches, memory problems, anxiety and depression. Learn more here.

“Pistol” Pete Pearson underwent psilocybin-assisted psychotherapy to ease his end-of-life distress, and calls it a game-changer. Rather than cursing the things he can no longer do, he’s grateful for the time he has left. Listen to all three episodes featuring Pistol on White Coat Black Art below. APPLE PODCASTS – SPOTIFY – CBC LISTEN … Read more

Des dizaines de médecins, psychologues et psychothérapeutes du Québec ont fait la demande pour que Santé Canada leur fournisse des doses de psilocybine, la substance active des champignons magiques, pour les expérimenter sur eux-mêmes. Lire l’article ici. — Dozens of doctors, psychologists and psychotherapists in Quebec have requested that Health Canada provide them with doses … Read more

While overseeing the case of a man charged with dealing magic mushrooms, a B.C. judge seemed to express his confusion that such crimes were even being prosecuted anymore. Read the full story from Tristan Hopper at the National Post.

In a landmark development for mental health care in Manitoba, the Enhanced Therapy Institute (ETI) has secured the first-ever Special Access Program (SAP) approval for MDMA-assisted therapy. Dr Darek Dawda and Dr Artur Winogrodzki share the details. Check it out here.

Read the full story from Kevin Rollason in the Winnipeg Free Press here.

FOR IMMEDIATE RELEASE First MDMA-Assisted Therapy for PTSD Approved in Manitoba A major step forward for access to mental health treatment in the province. WINNIPEG, MB, February 18, 2026 — In a landmark development for mental health care in the Prairies, the Enhanced Therapy Institute (ETI) has secured Manitoba’s first … Read more

Certain psychoactive substances can improve the mental health of terminally ill cancer patients—but few patients can currently access them. Read the full story here.

This qualitative study of how successful Psychedelic Assisted Psychotherapy (PAP) transforms the way of life of terminally ill subjects provides new knowledge for researchers and clinicians contemplating its use. Read the study here.

B.C.’s highest court has overturned a decision awarding the victim of a car crash $35,000 for psilocybin treatment, sending the matter back to the trial judge for redetermination. Read the story here.

After an 11-month wait for psilocybin therapy was denied by Health Canada, terminally ill Sarnia resident Pete Pearson was approved for MAID in less than a month, highlighting a systemic failure that is now pushing his family toward underground options. Read the full story here.

Following in the footsteps of U.S. academic giants such as Johns Hopkins, Imperial College and NYU, TheraPsil is seeking to unlock the potential of psilocybin through their own scientific research. Read more here.

Support Pete Pearson’s Section 56 Request Pete Pearson is a 75-year-old Canadian living with a terminal illness. After an 11-month wait, Pete was denied access to psilocybin-assisted psychotherapy to relieve end-of-life distress. You can read more about Pete’s case in the Sarnia Journal . Update (March 2026) Pete’s Section 56 request has now been refused. … Read more

FOR IMMEDIATE RELEASE World’s First Wellness-Focused Psychedelic Therapy Trial Launches in Canada Community-funded study will evaluate whether therapist-guided psychedelic therapy can enhance everyday wellness Victoria, BC, October 15, 2025 — A coalition of Canadian researchers, clinicians, and nonprofit advocates has received Health Canada authorization to launch PsilWell, the first clinical study … Read more

Older posts

Page1 Page2 … Page4 Next →

About

About Us
Our Team
Psychedelics
FAQ
Ethics
Privacy
Terms

Training

Psilocybin-Assisted Therapy
MDMA-Assisted Therapy
Prescriber Courses
Psychedelic First Aid & Preparedness

Care Pathways

Patients
Refer My Patient
Directory
Co-Sitter Directory

Advocacy

Thomas’ Bill
News
Legal Challenges
Reasoning
Psilocybin Regulations

Research

PsilWell Trial
Public Opinion
Global Evidence

Community

Events
Take Action
Volunteer
Newsletter
Allies
Contact

© 2026 TheraPsil - Website by West Coastal Creations